Senior Scientist, Patient Centered Outcomes, Oncology

GlaxoSmithKline ,
Brentford, Greater London
More Details

Overview

Job Description

As a Senior Scientist of Patient-Centered Outcomes for Oncology you will apply specialized technical expertise in support of GSK's exciting oncology portfolio to support Patient Reported Outcomes (PRO) / Clinical Outcome Assessment (COA) strategies. Our work in oncology is complex, but our goal is simple: transformational medicines to improve survival and potentially achieve cures. We're seeing promising results in our oncology work, where we focus on improving outcomes and outpacing the cancers we fight. Our portfolio focuses on four cutting edge areas of science: * immuno-oncology: using the human immune system to treat cancer * cell therapy: engineering human T-cells to target cancer * cancer epigenetics: modulating the epigenome, the information that directs how DNA is read and used, to induce anti-cancer effects * synthetic lethality: addressing two targets at the same time which together, but not alone, have substantial effects against cancer We believe that our approach of developing a pipeline of transformational products that fight cancer on multiple ground-breaking fronts will deliver a sustainable flow of innovative treatments for patients with the potential to have transformative effects on their disease. GSK's Patient Centered Outcomes (PCO) team has an integral role in in the development of integrated evidence plans to ensure that strong COA strategies support a patient-centric understanding of our oncology medicines. Our mission is to deliver 'do more, feel better' by implementing strong measurement science to capture the patient voice in demonstrating the value of our products to patients, physicians, payers and regulators. GSK's PCO team includes 10 directors, scientists and COA implementation specialists. The team has educational backgrounds across a range of COA disciplines and experience in pharmaceutical, regulatory and academic settings. We work in close partnership across GSK functions including clinical development, regulatory affairs, value evidence and outcomes and patient focused drug development. We are well connected with external initiatives to define, implement and interpret patient centric endpoints in drug development. We want to ensure that we have a focused view of our overall goals for the value of patient centric outcomes in oncology. We want to ensure that each development program has a well-characterized innovative COA strategy with plans to develop evidence supporting those endpoints. We build rigor into implementation of PROs into our clinical trials. This role will provide YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following: * Define and implement strategies for development and implementation of PRO/COAs across GSKs oncology portfolio * Develop global COA endpoint strategic plans to assure alignment with product goals; * Effectively communicate and execute COA strategies, assuring alignment with clinical, health outcomes and commercial strategies and overall clinical development plan * Coordinate and lead the development, validation, analysis, interpretation and utilization of instruments aimed at measuring COAs in the context of clinical trials and/or observational studies * Ensure PROs are implemented appropriately in clinical trials, including writing relevant portions of the clinical trial protocols,training investigative site personnel on PRO principles and appropriate administration of PROs in the clinical trials * Collaborate with clinical and statistical teams to ensure that COAs are appropriate analyzed and described in statistical analysis plans, study reports and publications * Prepare relevant sections of documentation and communication and questions for regulatory agency meetings, support and/or participate in meetings at regulatory agencies, and provide robust evidence in support of submission activities * Prepare abstracts and manuscripts presenting PRO results from clinical and PRO development and validation studies, aligned with publication strategy * Responsible for maintaining awareness of scientific, regulatory developments across GSKs oncology development programs incorporating new methodology and activities to establish communication with key outcomes research opinion leaders; * Keep up-to-date with methodologies and guidelines (including those from Regulatory Authorities) and communicate findings to VEO and functional groups as needed. Why you? Basic Qualifications: We are looking for professionals with these required skills to achieve our goals: * Master's degree in Psychology, Psychometrics, Social Sciences, Outcomes Research, Health services research, Epidemiology or a closely related discipline * Minimum 3 years of experience in a related role * Demonstrated experience with COA development and implementation in a pharmaceutical environment. Preferred Qualifications: If you have the following characteristics, it would be a plus: * Master's degree or PhD in Psychology, Psyc

People also viewed